CDKN2A and skin neoplasm: A randomized controlled trial enrolling 73 patients with high risk of developing skin cancers was conducted to compare the impact of a strategy of CDKN2A/MC1R counseling, giving test results (intervention group), to a strategy of not offering genetic counseling and test results (usual care) on behaviors and skin cancer risk awareness.